Glenmark Pharmaceuticals P/B Ratio

Current P/B Ratio
6.65
High Valuation
Very High - Significant premium, high growth expectations or speculative

Glenmark Pharmaceuticals P/B ratio. Glenmark Pharmaceuticals (GLENMARK) P/B ratio is 6.65 (High), book value per share ₹3754.29 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Read GLENMARK dividend growth for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 6.65
Current Price ₹2608.50
Book Value/Share ₹3754.29
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹10,512 Cr
Share Capital ₹28 Cr
Reserves & Surplus ₹10,484 Cr
Outstanding Shares 28,000,000
Book Value per Share ₹3754.29

Valuation Signal

Signal Overvalued
Historical Avg 0.45
Historical Range 0.13 - 0.69
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

GLENMARK P/B Ratio — Valuation Insights & Book Value Analysis

Glenmark Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 6.65 (High). Browse Glenmark Pharmaceuticals annual reports for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PB of 6.65, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 1364.8% above historical average
  • Trading at premium to sector average PB of -0.3

Glenmark Pharmaceuticals P/B Ratio Historical Trend

GLENMARK annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Glenmark Pharmaceuticals stock price NSE.

GLENMARK Historical P/B Ratio — Book Value Per Share & Year-End Price

Glenmark Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.69 ₹3754.29 ₹2608.50 ₹10,512 Low
2025 0.64 ₹3160.36 ₹2035.20 ₹8,849 Low
2024 0.57 ₹2802.86 ₹1609.10 ₹7,848 Low
2023 0.24 ₹3513.93 ₹853.95 ₹9,839 Low
2022 0.13 ₹3370.71 ₹424.15 ₹9,438 Low

GLENMARK vs Healthcare Peers — P/B Ratio Comparison

Glenmark Pharmaceuticals P/B 6.65 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low